Abstract
Objectives
The aim of this analysis is to examine the influence of gender differences on the outcome after transcatheter aortic valve implantation (TAVI) from a multicenter real-world registry in Germany (TAVI registry).
Background
The impact of gender differences on the clinical outcome after TAVI was examined in small studies with conflicting results.
Methods
Consecutive patients (n = 1,432) undergoing TAVI in the period between January 2009 and June 2010 in Germany were evaluated. Differences in all-cause mortality were examined with Kaplan–Meier estimates and proportional hazards models.
Results
Women comprised 57.8 % of the cohort. The Edwards Sapien valve (18.5 %) and CoreValve (81.5 %) were used through the transfemoral (87.7 %), subclavian (3.0 %), transapical (8.6 %), or transaortic approach (0.7 %). At baseline, women had higher aortic gradients and were older. Men had more comorbidities: prior myocardial infarction, prior revascularization, prior coronary artery bypass surgery, peripheral arterial vascular disease and chronic obstructive pulmonary disease. Women had more periprocedural vascular complications in comparison to men (25.2 vs. 17.2 %, p < 0.001). There was no significant difference in mortality at 30-day follow-up (7.6 % for women vs. 8.6 % for men, p = 0.55). The adjusted HR for 1-year all-cause mortality favored women, HR 0.75 (95 % CI 0.57–0.98, p = 0.0346) with a mortality rate of 17.3 vs. 23.6 % for men.
Conclusions
Female gender is associated with better 1-year survival after TAVI. These results suggest that TAVI could be the best treatment modality for elderly women with symptomatic severe aortic stenosis.
Similar content being viewed by others
Abbreviations
- TAVI:
-
Transcatheter aortic valve implantation
- MACCE:
-
Major adverse cerebral and cardiovascular events
References
Figulla L, Neumann A, Figulla HR, Kahlert P, Erbel R, Neumann T (2011) Transcatheter aortic valve implantation: evidence on safety and efficacy compared with medical therapy. A systematic review of current literature. Clin Res Cardiol 100:265–276
Puls M, Viel T, Danner BC, Jacobshagen C, Teucher N, Hanekop G, Schondube F, Hasenfuss G, Seipelt RG, Schillinger W (2012) The risk-to-benefit ratio of transcatheter aortic valve implantation in specific patient cohorts: a single-centre experience. Clin Res Cardiol 101:553–563
Onorati F, D’Errigo P, Barbanti M, Rosato S, Covello RD, Maraschini A, Ranucci M, Santoro G, Tamburino C, Grossi C, Santini F, Menicanti L, Seccareccia F, on behalf of the Group OR (2013) Different impact of sex on baseline characteristics and major periprocedural outcomes of transcatheter and surgical aortic valve interventions: results of the multicenter italian OBSERVANT registry. J Thorac Cardiovasc Surg. doi: 10.1016/j.jtcvs.2013.05.039
Humphries KH, Toggweiler S, Rodes-Cabau J, Nombela-Franco L, Dumont E, Wood DA, Willson AB, Binder RK, Freeman M, Lee MK, Gao M, Izadnegahdar M, Ye J, Cheung A, Webb JG (2012) Sex differences in mortality after transcatheter aortic valve replacement for severe aortic stenosis. J Am Coll Cardiol 60:882–886
Hayashida K, Morice MC, Chevalier B, Hovasse T, Romano M, Garot P, Farge A, Donzeau-Gouge P, Bouvier E, Cormier B, Lefevre T (2012) Sex-related differences in clinical presentation and outcome of transcatheter aortic valve implantation for severe aortic stenosis. J Am Coll Cardiol 59:566–571
Buchanan GL, Chieffo A, Montorfano M, Maisano F, Latib A, Godino C, Cioni M, Gullace MA, Franco A, Gerli C, Alfieri O, Colombo A (2011) The role of sex on VARC outcomes following transcatheter aortic valve implantation with both Edwards Sapien and Medtronic CoreValve ReValving System® devices: the Milan registry. EuroIntervention 7:556–563
Zhao ZG, Liao YB, Peng Y, Chai H, Liu W, Li Q, Ren X, Wang XQ, Luo XL, Zhang C, Lu LH, Meng QT, Chen C, Chen M, Feng Y, Huang DJ (2013) Sex-related differences in outcomes after transcatheter aortic valve implantation: a systematic review and meta-analysis. Circ Cardiovascu Interv 6:543–551
Zahn R, Gerckens U, Grube E, Linke A, Sievert H, Eggebrecht H, Hambrecht R, Sack S, Hauptmann KE, Richardt G, Figulla HR, Senges J (2011) German transcatheter aortic valve interventions-registry I. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 32:198–204
Zahn R, Gerckens U, Linke A, Sievert H, Kahlert P, Hambrecht R, Sack S, Abdel-Wahab M, Hoffmann E, Schiele R, Schneider S, Senges J (2013) German transcatheter aortic valve interventions-registry I. Predictors of one-year mortality after transcatheter aortic valve implantation for severe symptomatic aortic stenosis. Am J Cardiol 112:272–279
D’Ascenzo F, Gonella A, Moretti C, Omede P, Salizzoni S, La Torre M, Giordana F, Barbanti M, Ussia GP, Brambilla N, Bedogni F, Gaita F, Tamburino C, Sheiban I (2013) Gender differences in patients undergoing TAVI: a multicentre study. EuroIntervention 9:367–372
Petrov G, Regitz-Zagrosek V, Lehmkuhl E, Krabatsch T, Dunkel A, Dandel M, Dworatzek E, Mahmoodzadeh S, Schubert C, Becher E, Hampl H, Hetzer R (2010) Regression of myocardial hypertrophy after aortic valve replacement: faster in women? Circulation 122:S23–S28
Stangl V, Baldenhofer G, Knebel F, Zhang K, Sanad W, Spethmann S, Grubitzsch H, Sander M, Wernecke KD, Baumann G, Stangl K, Laule M (2012) Impact of gender on three-month outcome and left ventricular remodeling after transfemoral transcatheter aortic valve implantation. Am J Cardiol 110:884–890
Buellesfeld L, Stortecky S, Kalesan B, Gloekler S, Khattab AA, Nietlispach F, Delfine V, Huber C, Eberle B, Meier B, Wenaweser P, Windecker S (2013) Aortic root dimensions among patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. JACC Cardiovasc Interv 6:72–83
Roques F, Nashef SA, Michel P, Gauducheau E, de Vincentiis C, Baudet E, Cortina J, David M, Faichney A, Gabrielle F, Gams E, Harjula A, Jones MT, Pintor PP, Salamon R, Thulin L (1999) Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardio-Thoracic Surg 15:816–822 discussion 822-813
Smith CR, Leon MB, Mack MJ, Miller DC, Moses JW, Svensson LG, Tuzcu EM, Webb JG, Fontana GP, Makkar RR, Williams M, Dewey T, Kapadia S, Babaliaros V, Thourani VH, Corso P, Pichard AD, Bavaria JE, Herrmann HC, Akin JJ, Anderson WN, Wang D, Pocock SJ, Investigators PT (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198
Acknowledgments
The centers participating in the German Transcatheter Aortic Valve Interventions Registry are reported elsewhere [8]. Drs. Gerckens, Sievert, and Sack worked as proctors for either Medtronic, Inc., or Edwards Lifesciences or both and received speaker’s honoraria. Dr. Sievert is a member of the scientific advisory board for JenaValve Technology, Munich, Germany. Dr. Zahn has received research funding from Medtronic, Inc., and Edwards Lifesciences.
Author information
Authors and Affiliations
Corresponding author
Additional information
On behalf of the German Transcatheter Aortic Valve Interventions, Registry Investigators.
Rights and permissions
About this article
Cite this article
Sherif, M.A., Zahn, R., Gerckens, U. et al. Effect of gender differences on 1-year mortality after transcatheter aortic valve implantation for severe aortic stenosis: results from a multicenter real-world registry. Clin Res Cardiol 103, 613–620 (2014). https://doi.org/10.1007/s00392-014-0690-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-014-0690-6